Marker Therapeutics (MRKR) Non Operating Investment Income (2013 - 2015)
Marker Therapeutics (MRKR) reported Non Operating Investment Income of -$9.3 million for Q1 2015, down 9740.45% quarter-over-quarter from -$94640.0 in Q3 2014.
Marker Therapeutics (MRKR) Non Operating Investment Income (2013 - 2015) Analysis & Trends
Marker Therapeutics (MRKR) has 3 years of Non Operating Investment Income data on file, last reported at -$9.3 million in Q1 2015.
- Non Operating Investment Income for Q1 2015 came in at -$9.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was -$9.3 million (changed N/A YoY), and the FY2015 annual result was -$9.3 million, changed N/A from the prior year.
- Non Operating Investment Income retreated to -$9.3 million in Q1 2015 per MRKR's latest filing, from -$94640.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at -$94640.0 in Q3 2014 and troughed at -$9.3 million in Q1 2015.
- A 3-year average of -$3.2 million and a median of -$168392.0 in 2013 frame the typical range for Non Operating Investment Income.
- On a YoY basis, Non Operating Investment Income climbed as much as 43.8% in 2014 and fell as far as 43.8% in 2014.
- A 3-year view of Non Operating Investment Income shows it stood at -$168392.0 in 2013, then soared by 43.8% to -$94640.0 in 2014, then sank by 9740.45% to -$9.3 million in 2015.
- Business Quant data shows MRKR's Non Operating Investment Income at -$9.3 million in Q1 2015, -$94640.0 in Q3 2014, and -$168392.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 230,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | -9.31 Mn |
| Mar 31, 2015 | -9.31 Mn |
| Sep 30, 2014 | -94,640.00 |
| Sep 30, 2014 | -94,640.00 |
| Sep 30, 2013 | -168,392.00 |
| Sep 30, 2013 | -168,392.00 |